Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Immunology

HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse

Abstract

Human leukocyte antigens (HLA) class I molecules restrict the interaction between cytotoxic T cells and target cells. Abnormalities in HLA class I antigen expression and/or function may provide tumor cells with a mechanism for escaping immune surveillance and resisting T cell-based immunotherapies. The potential for applying T cell-based immunotherapy in the treatment of acute myeloid leukemia (AML) has stimulated interest in analyzing HLA class I antigen expression on leukemic blasts in this disease. Little information is available in the literature. We have analyzed HLA class I antigen expression on bone marrow samples from 25 newly diagnosed AML patients by indirect immunofluorescence staining with monoclonal antibodies. Five of these patients were also studied at relapse. Leukemic blasts were resolved from normal lymphocytes by staining with anti-CD45 antibody; CD45 expression is dim on leukemia cells, but bright on lymphocytes. HLA class I antigen expression was higher on leukemic blasts than on autologous lymphocytes in all but one case. Moreover, there was no significant change in HLA class I antigen expression at relapse. These results suggest that abnormalities in HLA class I antigens are infrequent in AML and should not represent a major obstacle to the application of T cell-based immunotherapies in this disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Ferrone S, Marincola FM . Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance Immunol Today 1995 16: 487–494

    Article  CAS  PubMed  Google Scholar 

  2. D'Alfonso S, Savoia P, Pitti G, Peruccio D, Pozzi C, Crepaldi T, Falda M, Ficara F, Resegotti L, Momigliano Richiardi P . Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells Eur J Immunogenet 1993 20: 165–173

    Article  CAS  PubMed  Google Scholar 

  3. Savoia P, D'Alfonso S, Peruccio D, Isabella N, Falda M, Rasegotti L, Richiardi P . Loss of surface HLA class I molecules in leukemic myeloblasts is correlated with an increased leukocyte concentration at onset Haematologica 1992 77: 127–129

    CAS  PubMed  Google Scholar 

  4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625

    Article  CAS  PubMed  Google Scholar 

  5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol 1991 78: 325–329

    Article  CAS  PubMed  Google Scholar 

  6. Mitelman F (ed) . ISCN: An International System for Human Cytogenetic Nomenclature Karger: Basel 1995

    Google Scholar 

  7. Wetzler M, Baer MR, Bernstein SH, Blumenson L, Stewart C, Barcos M, Mrozek K, Block AW, Herzig GP, Bloomfield CD . Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy J Clin Oncol 1997 15: 2262–2268

    Article  CAS  PubMed  Google Scholar 

  8. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, Sawitsky A, Stass S, Weinstein H, Woods WG . Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia J Clin Oncol 1990 8: 813–819

    Article  CAS  PubMed  Google Scholar 

  9. Desai SA, Wang X, Noronha EJ, Zhou Q, Rebmann V, Grosse-Wilde H, Moy FJ, Powers R, Ferrone S . Structural relatedness of distinct determinants recognized by mAb TP25.99 on b2-m associated and b2-m free HLA class I heavy chains J Immunol 2000 165: 3275–3283

    Article  CAS  PubMed  Google Scholar 

  10. Yang SY, Morishima Y, Collins NH, Alton T, Pollack MS, Yunis EJ, Dupont B . Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes Immunogenetics 1984 19: 217–231

    Article  CAS  PubMed  Google Scholar 

  11. Tsujisaki M, Sakaguchi K, Igarashi M, Richiardi P, Perosa F, Ferrone S . Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1 Transplantation 1988 45: 632–639

    Article  CAS  PubMed  Google Scholar 

  12. Sakaguchi K, Ono R, Tsujisaki M, Richiardi P, Carbonara A, Park MS, Tonai R, Terasaki PI, Ferrone S . Anti-HLA-B7, B27, Bw42, Bw54, Bw55, Bw56, Bw67, Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay Hum Immunol 1988 21: 193–207

    Article  CAS  PubMed  Google Scholar 

  13. Pellegrino MA, Ng AK, Russo C, Ferrone S . Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules Transplantation 1982 34: 18–23

    Article  CAS  PubMed  Google Scholar 

  14. Stewart CC . Clinical applications of flow cytometry: immunologic methods for measuring cell membrane and cytoplasmic antigens Cancer 1992 69: (Suppl.) 1543–1552

    Article  CAS  PubMed  Google Scholar 

  15. Riedy MC, Muirhead KA, Jensen CP, Stewart CC . The use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations Cytometry 1991 12: 133–139

    Article  CAS  PubMed  Google Scholar 

  16. Clinical Application of Flow Cytometry: Immunophenotyping of Leukemic Cells; Proposed Guidelines Document H43-P National Committee for Clinical Laboratory Standards: Villanova, PA 1993

  17. Snedecor G, Cochran W . Statistical Methods, 8th edn, Iowa State University Press: Iowa 1989 pp 138–142

  18. Neter J, Wasserman W, Kutner M . Applied Linear StatisticalModels Irwin: Boston 1990 pp 646–647

  19. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringden O, Speck B, Weiner RS, Bortin MM . T-cell depletion of HLA-identical transplants in leukemia Blood 1991 78: 2120–2130

    CAS  PubMed  Google Scholar 

  20. Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB, Messner HA, Rimm AA, Rozman C, Speck B, Tura S, Weiner RS . Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion Ann Intern Med 1988 108: 806–814

    Article  CAS  PubMed  Google Scholar 

  21. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H . Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041–2050

    CAS  PubMed  Google Scholar 

  22. Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J . Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433–444

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported partially by Public Health Service Grants CA 16056 and CA 67108 awarded by the National Cancer Institute, US Department of Health and Human Services.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wetzler, M., Baer, M., Stewart, S. et al. HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse. Leukemia 15, 128–133 (2001). https://doi.org/10.1038/sj.leu.2401982

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401982

Keywords

This article is cited by

Search

Quick links